Unlocking the Potential of 4EHP-GYF2: A drug Target and Biomarker

Target Name: 4EHP-GYF2 complex

NCBI ID: P38467

4EHP-GYF2 complex

Other Name(s): None

Unlocking the Potential of 4EHP-GYF2: A drug Target and Biomarker

Introduction

The 4EHP-GYF2 complex is a protein that plays a crucial role in cellular signaling, particularly in the regulation of cell adhesion and migration. Extracellular matrix (ECM) proteins, such as 4EHP-GYF2, have been identified as potential drug targets and biomarkers for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. In this article, we will explore the 4EHP-GYF2 complex, its functions, and the potential for its development as a drug target and biomarker.

4EHP-GYF2: A Protein Regulating Cell Adhesion and Migration

4EHP-GYF2, also known as E-cadherin, is a non-coding protein that is expressed in various tissues and cells. It is a member of the cadherin family, which includes other proteins involved in cell-cell adhesion, such as CD73 and CD76. 4EHP-GYF2 is characterized by its four transmembrane domains and a unique N-terminal region that contains a unique amino acid sequence.

4EHP-GYF2 functions as a negative regulator of cell adhesion, preventing cells from sticking to each other and forming tight junctions. This function is critical for maintaining tissue structure and function, as well as for the proper functioning of tissues and organs. In addition to Its role in cell adhesion, 4EHP-GYF2 is also involved in the regulation of cell migration, which is essential for the development and maintenance of tissues and organs during development and throughout life.

4EHP-GYF2 as a Drug Target: Potential Targets and Strategies

The 4EHP-GYF2 complex has been identified as a potential drug target for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. One of the main reasons for its potential as a drug target is its involvement in several key signaling pathways, including the TGF-β pathway and the Wnt pathway.

1. TGF-β Signaling Pathway

TGF-β is a critical signaling pathway involved in the regulation of cell growth, differentiation, and inflammation. 4EHP-GYF2 has been shown to play a negative role in the regulation of TGF-β signaling, which suggests that it may be a potential target for drugs that target this pathway.

2. Wnt Signaling Pathway

The Wnt signaling pathway is involved in the regulation of cell-cell adhesion and the development of tissues during development. 4EHP-GYF2 has been shown to be involved in the regulation of Wnt signaling, which suggests that it may be a potential target for drugs that target this pathway.

3.Other channels

In addition to the above two signaling pathways, 4EHP-GYF2 may also participate in other signaling pathways, including Notch signaling pathway. The research and development of these pathways may provide more ideas for drug development of 4EHP-GYF2.

4EHP-GYF2 as a Biomarker: Potential Applications

4EHP-GYF2 has also been identified as a potential biomarker for several diseases, including cancer. Its involvement in the regulation of cell adhesion and migration makes it an attractive candidate for use as a biomarker for these diseases. In addition, its unique amino acid sequence and its expression patterns in different tissues and cells make it a potential target for diagnostic biomarkers.

Conclusion

In conclusion, the 4EHP-GYF2 complex is a protein that plays a crucial role in

Protein Name: 4EHP-GYF2 Complex

The "4EHP-GYF2 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about 4EHP-GYF2 complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets